1.31. Analysis.
Comparison 1 Fluvoxamine versus TCAs, Outcome 31 Sensitivity analysis ‐ Response (acute phase) 9. Excluding trials that included patients with psychotic features.
Comparison 1 Fluvoxamine versus TCAs, Outcome 31 Sensitivity analysis ‐ Response (acute phase) 9. Excluding trials that included patients with psychotic features.